Chronic Myeloid Leukemia (CML)
What We Offer
Chronic myeloid leukemia (CML) is a cancer of the blood in which too many granulocytes, a type of white blood cell, are produced in the bone marrow. Our doctors provide exceptional care for chronic myelogenous leukemia through tailored care plans based on the most advanced diagnosis and treatment techniques, including novel therapies available through clinical trials.
INTERESTED IN AN ONLINE SECOND OPINION?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely, and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.
Clinical Trials for Chronic Myeloid Leukemia (CML)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Learn More About Chronic Myeloid Leukemia
What We Offer
Our providers use leading edge techniques to diagnose and treat chronic myelogenous leukemia (CML).
About this Condition
Learn about the symptoms, causes, and diagnosis of chronic myeloid leukemia (CML).
Patient Care Resources
Learn what to expect as you go through the early steps of your care.
To schedule an appointment, please call: 650-498-6000